Search
for
Sort by
Research 31–60 of 135
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- A modified laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 and metabolic syndrome in obesity
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) from a Young Age Due to a Rare Genetic Disorder, Familial Partial Lipodystrophy: A Case Report and Review of the Literature
- The Secretome of Irradiated Peripheral Mononuclear Cells Attenuates Hypertrophic Skin Scarring
- Cellulose and Its Derivatives-Based Skin Dressings: Design, Smart Advances and Applications
- Role of FGFR2-signaling in the pathogenesis of acne
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- [Retracted] Fibroblasts in Scar Formation: Biology and Clinical Translation
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Organoid‐Guided Precision Medicine: From Bench to Bedside
- Metabolic syndrome and dermatological diseases: association and treatment
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion